12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers

  • Stoke Therapeutics STOK stock increased by 80.2% to $11.71 during Tuesday's pre-market session. The market value of their outstanding shares is at $522.8 million. As per the press release, Q4 earnings came out yesterday.
  • OpGen OPGN shares moved upwards by 77.6% to $0.84. The market value of their outstanding shares is at $8.4 million.
  • ABVC BioPharma ABVC stock increased by 45.71% to $1.53. The market value of their outstanding shares is at $16.1 million.
  • Mesoblast MESO shares moved upwards by 32.27% to $2.91. The market value of their outstanding shares is at $295.3 million.
  • Praxis Precision Medicine PRAX shares increased by 21.38% to $61.3. The market value of their outstanding shares is at $811.5 million.
  • Sutro Biopharma STRO stock moved upwards by 18.96% to $3.89. The company's market cap stands at $237.1 million. The company's, Q4 earnings came out yesterday.

Losers

  • NeuBase Therapeutics NBSE stock decreased by 55.0% to $0.45 during Tuesday's pre-market session. The company's market cap stands at $1.6 million.
  • Tivic Health Systems TIVC shares fell 14.49% to $1.24. The company's market cap stands at $1.8 million. The company's, Q4 earnings came out yesterday.
  • bluebird bio BLUE shares fell 12.51% to $1.19. The company's market cap stands at $229.3 million. As per the press release, Q4 earnings came out today.
  • BioLine Rx BLRX stock declined by 11.54% to $1.15. The market value of their outstanding shares is at $83.3 million. The company's, Q4 earnings came out today.
  • iSpecimen ISPC stock fell 8.48% to $0.23. The market value of their outstanding shares is at $2.0 million.
  • IMAC Hldgs BACK stock decreased by 8.27% to $2.22. The company's market cap stands at $2.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!